U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

AC-2592 (glucagon-like peptide 1, or GLP-1) was being in development by Amylin Pharmaceuticals for the treatment of severe congestive heart failure. AC-2592 is a glucagon like peptide 1 receptor agonist.

Originator

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Gateways to clinical trials.
2010-05
Patents

Patents

08524726
5
20050070539
2
6756374
2
9212177
2
WO2011015037A1
2
WO2012044531A1
2
WO2013171334A1
2

Sample Use Guides

In Vivo Use Guide
Congestive Heart Failure: Continuous subcutaneous infusion (via pump), dose based on subject body weight
Route of Administration: Parenteral
Name Type Language
GLUCAGON-LIKE PEPTIDE-I(7-36) AMIDE
Common Name English
AC-2592
Preferred Name English
HUMAN GLP-1-(7-36)-AMIDE
Common Name English
BETATROPIN
Common Name English
GLP-1(7-36)AMIDE
Common Name English
(7-36)GLUCAGON-LIKE PEPTIDE-1 AMIDE (HUMAN)
Common Name English
GLP-1(7-36)
Common Name English
MKC 253
Code English
RAT GLP-I(7-36)AMIDE
Common Name English
GLP-1 (7-36) AMIDE
Common Name English
GLUCAGON-LIKE-PEPTIDE-1 (7-36) AMIDE
Common Name English
INSULINOTROPIN (HUMAN)
Common Name English
HUMAN GLUCAGON-LIKE PEPTIDE-1-(7-36) AMIDE
Common Name English
7-36-HUMAN GLUCAGON-LIKE PEPTIDE I AMIDE
Common Name English
GLUCAGON-LIKE PEPTIDE-I (7-36)
Common Name English
Code System Code Type Description
PUBCHEM
16133831
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
CAS
107444-51-9
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
FDA UNII
0JS9125PIZ
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
MANUFACTURER PRODUCT INFORMATION
GLUCAGON-LIKE PEPTIDE-I(7-36) AMIDE
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966